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Abstract
Background: Results from genome-wide association studies (GWAS) identified many loci and biological pathways
that influence adult body mass index (BMI). We aimed to identify if biological pathways related to adult BMI also
affect infant growth and childhood adiposity measures.
Methods: We used data from a population-based prospective cohort study among 3,975 children with a mean age
of 6 years. Genetic risk scores were constructed based on the 97 SNPs associated with adult BMI previously identified
with GWAS and on 28 BMI related biological pathways based on subsets of these 97 SNPs. Outcomes were infant peak
weight velocity, BMI at adiposity peak and age at adiposity peak, and childhood BMI, total fat mass percentage, android/
gynoid fat ratio, and preperitoneal fat area. Analyses were performed using linear regression models.
Results: A higher overall adult BMI risk score was associated with infant BMI at adiposity peak and childhood BMI, total
fat mass, android/gynoid fat ratio, and preperitoneal fat area (all p-values < 0.05). Analyses focused on specific biological
pathways showed that the membrane proteins genetic risk score was associated with infant peak weight velocity, and
the genetic risk scores related to neuronal developmental processes, hypothalamic processes, cyclicAMP, WNT-signaling,
membrane proteins, monogenic obesity and/or energy homeostasis, glucose homeostasis, cell cycle, and muscle
biology pathways were associated with childhood adiposity measures (all p-values <0.05). None of the pathways
were associated with childhood preperitoneal fat area.
Conclusions: A genetic risk score based on 97 SNPs related to adult BMI was associated with peak weight velocity
during infancy and general and abdominal fat measurements at the age of 6 years. Risk scores based on genetic variants
linked to specific biological pathways, including central nervous system and hypothalamic processes, influence body fat
development from early life onwards.
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Background
Childhood overweight and obesity are associated with
various adverse short- and long-term consequences, in-
cluding cardiovascular disease and type 2 diabetes [1–4].
Besides the well-known lifestyle-related risk factors, over-
weight and obesity have a strong genetic component with
heritability estimates from twin studies reported to be up
to 80 % [5, 6]. Large genome-wide association studies
(GWAS) have identified many single nucleotide polymor-
phisms (SNPs) associated with body mass index (BMI) in
adults [7, 8]. Less is known about the genetic background
of BMI in childhood. Three recent studies revealed a total
of 15 genetic loci associated with childhood BMI, most of
which are also associated with adult BMI [9–11]. We pre-
viously reported that a genetic risk score based on 29
SNPs related to adult BMI was associated with infant
growth and childhood adiposity measures [12]. A recent
GWAS increased the number of adult BMI associated
SNPs to 97 [8]. These SNPs are located in or close to
genes linked to several biological pathways. In adults espe-
cially central nervous system processes seem to play a role
[8]. The role of these pathways in body fat development
during early life is not known yet. Thus far, GWAS in chil-
dren did not report any specific biological pathways [11].
Knowledge on the biological pathways influencing BMI
from early life onwards may help to better understand the
development of overweight and obesity in children.
In this study, we used data from 3,975 children partici-
pating in a population-based cohort study to examine
the associations of genetic risk scores for adult BMI,
both overall and based on specific biological pathways,
with infant weight growth patterns and childhood adi-
posity measures. For comparison, we also examined the
associations of genetic risk scores based on the 49 SNPs
related with adult waist-hip-ratio (WHR) and on the 15
SNPs associated with childhood BMI with the same in-
fant and childhood outcomes [11, 13].
Methods
Study design and population
This study was embedded in the Generation R Study, a
population-based, prospective cohort study from fetal
life onwards in Rotterdam, the Netherlands [14]. All
pregnant women with an expected delivery date between
April 2002 and January 2006 and living in Rotterdam
were asked to participate. The study was approved by
the local Medical Ethical Committee and written con-
sent was obtained for each participating child. GWA
scans were available for 59 % of all children (N = 5,732)
[15]. The Generation R Study is a multi-ethnic cohort.
Participants of European origin constitute the largest
ethnic group (56 %), and the largest other groups are
Surinamese (9 %), Turkish (7 %) and Moroccan (6 %)
[14]. Our present study included all singleton live births
with GWA data and information on at least one of the
outcomes of interest (N = 4,151). A participant flowchart
is shown in Additional file 1: Figure S1.
Genetic variants and risk scores
DNA was isolated from cord blood or, in a small minor-
ity of children with missing cord blood samples, at
6 years of age. For genome-wide association analysis the
Illumina 610 and 660 W Quad platforms were used [16].
Stringent quality checks were performed in which indi-
viduals with low sample call rates (<97.5 %) or sex mis-
matches were excluded. Imputation of genotypes to the
cosmopolitan panel of HapMap ii (release 22) was done
using MACH software [17, 18]. Prior to imputation, we
excluded SNPs with a high level of missing data (SNP
call rate <98 %), significant deviations from Hardy-
Weinberg equilibrium (P < 1*10−6), or low minor allele
frequencies (<0.1 %). Information about the SNPs of
interest for the current study was extracted from the
GWAS dataset. The average imputation quality for all
SNPs included in this study was 0.96, ranging from 0.55 to
1.00, demonstrating overall good imputation. For 93 out of
the 97 known BMI SNPs information was available in our
GWA dataset. We used proxies (R2 > 0.96, D’ = 1) for the
remaining four BMI SNPs: rs13012571 was used as a proxy
for rs13021737, rs1978487 for rs9925964, rs6445197 for
rs2365389, and rs9636202 for rs17724992. Thus, the total
number of SNPs used in the analysis was 97 (Additional
file 2: Table S1). These SNPs were combined into weighted
BMI genetic risk scores (see below). The same procedure
was used for the 49 WHR and 15 child BMI SNPs [11, 13].
For 46 of the 49 WHR SNPs information was available
in the GWA dataset. Rs4607103 was used as a proxy
for rs2371767 (R2 = 0.90, D’ = 1). For the WHR SNPs
rs8042543 and rs6556301 no perfect proxy was avail-
able leading to a total number of SNPs of 47 for WHR.
For all but one SNPs identified for childhood BMI, infor-
mation was available in our dataset. We used rs3751812
as a proxy for rs1421085 (R2 = 0.93, D’ = 0.97) (Additional
file 2: Table S1).
In the paper on adult BMI, the 97 adult BMI SNPs
were categorized into pathway categories. The authors
performed a literature search, which brought about 405
genes within 500 kb on either side and with r2 > 0.2 of
the 97 SNPs [8]. Based on their biological function, these
genes were then catagorized into 28 pathways. We used
this same categorization, but we excluded categories con-
sisting of one SNP only. For each pathway category, we
combined SNPs into a weighted genetic risk score. Some
SNPs were included in more than one category based on
their biological function (Additional file 3: Table S2). The
number of overlapping SNPs between the biological
categories is shown in Additional file 4: Table S3. As a
comparison we ran a pathway analysis using QIAGEN’s
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Ingenuity® Pathway Analysis software (IPA) (IPA®, QIAGEN
Redwood City,www.qiagen.com/ingenuity).
Infant weight growth and childhood general and
abdominal adiposity
We used repeated growth measurements to derive in-
fant peak weight velocity (PWV), BMI at adiposity peak
(BMIAP) and age at adiposity peak (AGEAP), as de-
scribed previously [19–23]. Briefly, the Reed1 model
was used for boys and girls separately, to obtain PWV
during infancy. BMIAP and AGEAP were obtained by
fitting a cubic mixed effects model on log (BMI) from
2 weeks to 1.5 years of age while adjusting for sex.
At the median age of 6.0 years (95 % range, 5.7, 7.4) we
measured general and abdominal adiposity measures as
described in detail previously [24]. Briefly, BMI (kg/m2)
was calculated from height and weight measured without
shoes and heavy clothing. Total, android, and gynoid fat
mass were measured by Dual-energy X-ray absorptiometry
(DXA) (iDXA, GE-Lunar, 2008, Madison, WI, USA) [24].
Total fat mass (kg) was calculated as a percentage of total
body weight (kg). Android/gynoid fat ratio provides the ra-
tio of central body fat distribution in the abdomen (android
fat) and hip (gynoid fat) regions [25]. Preperitoneal fat area,
which is a measure of visceral abdominal fat, was measured
by abdominal ultrasound [24, 26, 27].
Statistical analysis
We constructed a weighted genetic risk score combining
the 97 adult BMI SNPs summing the number of out-
come increasing risk alleles from the GWA dosage data,
weighted using effect estimates of risk increasing alleles
in adults. The risk score was rescaled to standard de-
viation scores (SDS, (observed value-mean)/standard
deviation (SD)). Similarly, we constructed genetic risk
scores based on SNPs involved in 28 different biological
categories, and based on 47 adult WHR SNPs and 15
childhood BMI SNPs. For the biological categories and
the WHR SNPs, we used the effect estimates from the
original papers as weights [8, 11, 13]. For the 15 child-
hood SNPs, weights were obtained from the GWAS
meta-analysis without the Generation R data [11]. We
used linear regression analyses to examine the associa-
tions of the risk scores with PWV, BMIAP, and AGEAP
in infancy, and BMI, total fat mass percentage, android/
gynoid fat ratio, and preperitoneal fat area in childhood.
The variance explained by the risk scores was considered
to be the increase in the unadjusted R2 between the
model containing all covariates and the risk score or
separate SNPs, and the same model without the risk
score. For all analyses, we natural logarithm transformed
total fat mass, android/gynoid fat ratio, and preperito-
neal fat area to obtain a normal distribution. Standard
deviation scores were created for all outcome measures
to allow comparison of effect estimates. For BMI, age-
adjusted SD scores were created using the Dutch refer-
ence growth curves (Growth Analyzer 3.0, Dutch Growth
Research Foundation, Rotterdam, the Netherlands) [12].
To enable comparison with our current risk scores, we
rescaled the previously published 29 adult BMI SNPs risk
score to SD scores. All models were adjusted for sex plus
the first four principal components from the genetic
data to adjust for ethnic background [28]. Models for
general and abdominal adiposity measures were add-
itionally adjusted for age except for BMI which was
already age adjusted. Models for total fat mass, an-
droid/gynoid fat ratio, and preperitoneal fat area were
additionally adjusted for height. [24] We also tested
whether the associations of the child and adult BMI
risk scores with the childhood adiposity outcomes were
explained by infant growth by adding PWV and BMIAP
separately to the regression models. For the analyses of
the 28 biological pathways, we applied Bonferroni cor-
rection and considered a p-value of <0.0018 (0.05/28)
as significant. All analyses were performed using the
Statistical Package for the Social Sciences version 21.0
for Windows (SPSS; IBM, Chicago, IL, USA).
Results
Characteristics of the study population
Characteristics of all children are listed in Table 1. The
children had a median age of 6.0 years (95 % range 5.7,
7.4). The median BMI at that age was 15.8 (95 % range
13.7, 21.2).
Infant weight growth patterns
The overall adult BMI genetic risk score was associated
with BMIAP (Table 2; Fig. 1a-c), but not with other in-
fant weight growth measures. BMIAP increased by
0.048 SDS (95 % confidence interval (CI) 0.015, 0.081)
per SD increase in the genetic risk score. Of the 28
adult BMI genetic risk scores based on biological path-
ways, only the membrane proteins pathway genetic risk
score was associated with PWV (p-value <0.002). Effect
estimates for the unweighted and weighted 97 adult
BMI SNPs risk scores were similar (Additional file 5:
Table S4). As a comparison, the overall adult WHR
genetic risk score was not associated with any infant
growth measure (Table 2; Additional file 6: Figure S2a-c),
whereas the childhood BMI genetic risk score was associ-
ated with PWV and BMIAP (0.048 SDS (95 % CI 0.016,
0.079) and 0.051 SDS (0.017, 0.084), respectively, per SD
increase in the genetic risk score) (Table 2; Additional file
7: Figure S3a-c). The genetic risk score based on 29 adult
BMI SNPs showed lower effect estimates per SD increase
than our 97 SNPs adult BMI risk score for PWV and
BMIAP, and a higher effect estimate for AGEAP, although
none of the associations were significant for the 29 SNP
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genetic risk score (Additional file 8: Table S5). The largest
variance explained by the adult BMI and pathway risk
scores was obtained for the membrane proteins pathway
with PWV (0.33 %) (Additional file 9: Table S6).
General and abdominal adiposity at school-age
The overall adult BMI genetic risk score was associated
with all childhood general and abdominal adiposity mea-
sures. For each SD increase in the genetic risk score,
childhood BMI increased by 0.112 SDS (95 % CI 0.084,
0.141), total fat mass increased by 0.092 SDS (95 % CI
0.065, 0.119), android/gynoid fat ratio increased by 0.077
SDS (95 % CI 0.045, 0.108), and increased preperitoneal
fat area by 0.034 SDS (95 % CI 0.001, 0.066) (Table 3;
Fig. 2a-d). Effect estimates for the unweighted and
weighted 97 adult BMI SNPs risk scores were similar
(Additional file 5: Table S4). Addition of PWV to the re-
gression models did not materially change the effect esti-
mates for the association of the BMI risk scores with
BMI, total fat mass percentage, and android/gynoid fat
ratio. However, the effect estimate for the association of
the adult BMI risk score with childhood preperitoneal
fat area was no longer significant. We observed similar
findings when we added BMIAP instead of PWV to
these regression models. However, the effects on the as-
sociations of the BMI risk scores with BMI and total fat
mass were somewhat larger. Effect estimates for the as-
sociations of the child BMI risk score with BMI and
total fat mass were 10–15 % lower after additional ad-
justment for PWV. Effect estimates for android/gynoid
fat ratio and preperitoneal fat area did not materially
change. We observed similar findings after additional
adjustment for BMIAP (Additional file 10: Table S7 and
Additional file 11: Table S8).
Of the 28 adult BMI genetic risk scores based on the
biological pathways, those based on neuronal develop-
mental processes, hypothalamic expression and regula-
tion, WNT-signaling, membrane proteins, monogenic
obesity/energy homeostasis, glucose homeostasis/dia-
betes, and muscle biology were associated with child-
hood BMI (all p-values <0.0018). Genetic risk scores
based on hypothalamic expression and regulation, cycli-
cAMP, monogenic obesity/energy homeostasis, and cell
cycle were associated with total fat mass, whereas for an-
droid/gynoid fat ratio only the genetic risk scores based
on hypothalamic expression and regulation, membrane
proteins, and monogenic obesity/energy homeostasis
show significant associations (all p-values <0.0018).
None of the pathways were associated with preperitoneal
fat area (Table 3). We based our pathway risk scores on
these biological categories to keep our analysis as close
as possible to the analysis of the original paper as
Table 1 Characteristics of the study population
Characteristics Full group
(N = 3,975)
European
(N = 2,566)
Turkish
(N = 300)
Surinamese
(N = 287)
Moroccan
(N = 234)
Other
(N = 588)
Birth
Boys 50.2 % 49.6 % 53.7 % 53.3 % 50.4 % 49.2 %
Gestational age at birth (weeks)a 40.1 (36.4; 42.3) 40.3 (33.3; 42.0) 40.0 (36.2; 42.3) 39.7 (35.7; 42.0) 40.6 (36.4; 42.2) 40.0 (36.4; 42.1)
Weight at birth (grams) 3458 (514) 3506 (514) 3402 (480) 3238 (536) 3496 (426) 3379 (506)
Infant
Peak weight velocity (kg/year) 12.2 (2.1) 12.0 (2.0) 13.1 (2.4) 12.5 (2.2) 12.6 (2.1) 12.4 (2.2)
Body mass index at adiposity peak (kg/m2) 17.6 (0.8) 17.5 (0.8) 17.9 (0.9) 17.5 (0.9) 17.8 (0.8) 17.7 (0.8)
Age at adiposity peak (years) 0.7 (0.04) 0.7 (0.04) 0.7 (0.04) 0.7 (0.04) 0.7 (0.04) 0.7 (0.04)
Childhood
Age at visit (years)a 6.0 (5.7; 7.8) 6.0 (5.7; 7.5) 6.1 (5.7; 7.7) 6.1 (5.5; 8.2) 6.1 (5.7; 8.3) 6.1 (5.7; 8.2)
Height (cm) 119.6 (6.0) 119.5 (5.6) 119.0 (5.7) 119.9 (7.0) 119.1 (5.9) 120.1 (4.9)
Weight (kg) 23.3 (4.2) 22.9 (3.6) 24.5 (5.3) 23.5 (5.3) 23.9 (4.1) 24.0 (4.9)
Body mass index (kg/m2)a 15.8 (13.7; 21.3) 15.7 (13.7; 19.8) 16.6 (13.6; 24.2) 15.7 (13.2; 23.3) 16.4 (14.0; 22.0) 16.2 (13.6; 22.0)
Total fat mass percentagea 24.0 (16.3; 38.6) 23.5 (16.4; 36.4) 26.6 (18.3; 43.5) 24.1 (14.8; 41.4) 25.9 (17.8; 39.9) 24.3 (15.9; 39.4)
Android-gynoid fat ratioa 0.2 (0.2; 0.4) 0.2 (0.2; 0.4) 0.3 (0.2; 0.5) 0.2 (0.2; 0.5) 0.2 (0.2; 0.4) 0.2 (0.1; 0.4)
Preperitoneal fat area (cm2)a 0.4 (0.2; 1.2) 0.4 (0.2; 1.0) 0.5 (0.2; 1.9) 0.4 (0.2; 1.7) 0.4 (0.2; 1.6) 0.4 (0.2; 1.3)
Overweight (%)b 12.9 10.5 23.7 11.8 19.7 17.8
Obese (%)b 4.1 2.1 11.0 8.0 7.7 6.1
N = 3,975
Values are means (standard deviations) unless otherwise specified
aMedian (95 % range)
bThe IOTF-classification was used to define overweight and obesity [41]
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Table 2 Associations of BMI, WHR, and childhood BMI genetic risk scores with infant growth (N = 2,955)a
Risk score (number of SNPs in risk
score)
Peak weight velocityb BMI at adiposity peakb Age at adiposity peakb
Beta (CI 95 %) P-value Beta (CI 95 %) P-value Beta (CI 95 %) P-value
Main risk scores*
Adult BMI (N = 97) 0.027 (−0.004; 0.058) 0.093 0.048 (0.015; 0.081) 0.005 0.015 (−0.021; 0.051) 0.418
Secondary risk scores
Adult WHR (N = 47) −0.022 (−0.054; 0.010) 0.180 −0.010 (−0.044; 0.025) 0.587 −0.016 (−0.053; 0.022) 0.411
Child BMI (N = 15) 0.038 (0.007; 0.070) 0.018 0.039 (0.006; 0.073) 0.023 0.027 (−0.010; 0.063) 0.153
Adult BMI pathway genetic risk scores**
Neuronal
Neuronal developmental processes
(N = 29)
0.036 (0.003; 0.070) 0.031 0.049 (0.013; 0.084) 0.007 −0.020 (−0.058; 0.019) 0.311
Neurotransmission (N = 10) −0.009 (−0.040; 0.022) 0.558 −0.001 (−0.034; 0.032) 0.948 0.002 (−0.034; 0.038) 0.901
Hypothalamic expression and
regulation (N = 13)
0.001 (−0.030; 0.033) 0.932 0.008 (−0.025; 0.042) 0.637 0.023 (−0.013; 0.059) 0.203
Neuronal expression (N = 12) −0.034 (−0.065; −0.003) 0.034 −0.010 (−0.044; 0.024) 0.559 0.026 (−0.010; 0.062) 0.159
Lipid biosynthesis and metabolism
(N = 10)
0.002 (−0.030; 0.033) 0.918 0.006 (−0.028; 0.040) 0.358 0.020 (−0.017; 0.056) 0.291
Bone development (N = 9) 0.017 (−0.014; 0.048) 0.290 0.017 (−0.017; 0.050) 0.336 0.001 (−0.035; 0.037) 0.957
Signaling
MAPK1/extracellular signal-regulated
kinases (N = 9)
0.009 (−0.022; 0.040) 0.579 0.008 (−0.025; 0.042) 0.625 0.011 (−0.025; 0.047) 0.534
JAK (N = 2) −0.007 (−0.038; 0.025) 0.679 −0.005 (−0.038; 0.029) 0.779 −0.006 (−0.042; 0.030) 0.750
CyclicAMP (N = 5) −0.020 (−0.052; 0.013) 0.233 0.019 (−0.015; 0.054) 0.368 −0.016 (−0.053; 0.021) 0.391
WNTSignaling (N = 6) 0.033 (0.001; 0.064) 0.041 0.017 (−0.016; 0.051) 0.311 0.019 (−0.017; 0.055) 0.293
G-protein coupled receptor
Notch signaling (N = 2) 0.010 (−0.021; 0.041) 0.531 0.009 (−0.024; 0.043) 0.581 0.012 (−0.024; 0.048) 0.508
Mitochondrial (N = 8) 0.010 (−0.023; 0.043) 0.559 0.004 (−0.032; 0.039) 0.840 0.039 (0.001; 0.077) 0.046
Retinoic acid receptors (N = 6) 0.019 (−0.013; 0.050) 0.245 0.025 (−0.009; 0.058) 0.144 0.019 (−0.017; 0.055) 0.308
Endocytosis/exocytosis (N = 14) 0.004 (−0.027; 0.036) 0.778 0.005 (−0.028; 0.038) 0.776 0.007 (−0.029; 0.043) 0.699
Eye-related (N = 5) 0.010 (−0.022; 0.042) 0.548 0.010 (−0.025; 0.045) 0.567 −0.030 (−0.067; 0.007) 0.116
Tumorigenesis (N = 11) 0.018 (−0.015; 0.050) 0.285 0.018 (−0.017; 0.052) 0.320 −0.001 (−0.038; 0.036) 0.954
Apoptosis (N = 13) 0.027 (−0.004; 0.059) 0.087 0.018 (−0.016; 0.052) 0.294 0.033 (−0.004; 0.069) 0.077
Membrane proteins (N = 12) 0.057 (0.025; 0.088) 3.88*10−4 0.048 (0.015; 0.082) 0.005 0.028 (−0.008; 0.065) 0.124
Hormone metabolism/regulation
(N = 4)
−0.009 (−0.041; 0.022) 0.564 −0.009 (−0.042; 0.025) 0.610 0.010 (−0.027; 0.046) 0.604
Purine/pyrimidine cycle (N = 4) 0.009 (−0.022; 0.041) 0.557 0.039 (0.006; 0.073) 0.023 −0.025 (−0.061; 0.011) 0.178
Monogenic obesity/energy
homeostasis (N = 9)
−0.013 (−0.045; 0.018) 0.406 −0.014 (−0.048; 0.020) 0.413 0.026 (−0.011; 0.062) 0.168
Immune system (N = 15) 0.045 (0.014; 0.076) 0.005 0.049 (0.015; 0.082) 0.004 −0.003 (−0.039; 0.033) 0.868
Limb development (N = 3) 0.018 (−0.014; 0.049) 0.267 0.022 (−0.011; 0.056) 0.195 0.001 (−0.035; 0.037) 0.945
Ubiquitin pathways (N = 6) −0.006 (−0.038; 0.025) 0.684 0.007 (−0.027; 0.040) 0.693 −0.025 (−0.061; 0.011) 0.168
Glucose homeostasis/diabetes
(N = 11)
0.023 (−0.009; 0.054) 0.160 0.021 (−0.013; 0.055) 0.219 0.026 (−0.010; 0.063) 0.156
Cell cycle (N = 23) 0.008 (−0.023; 0.039) 0.611 0.011 (−0.023; 0.044) 0.538 −0.001 (−0.037; 0.035) 0.959
DNARepair
Nuclear trafficking (N = 4) −0.015 (−0.047; 0.017) 0.362 −0.023 (−0.057; 0.011) 0.187 −0.032 (−0.068; 0.005) 0.092
Muscle biology (N = 6) −0.011 (−0.043; 0.020) 0.479 −0.0003 (−0.034; 0.033) 0.985 0.014 (−0.022; 0.050) 0.446
* Bold font indicates P-value < 0.05. ** Bold font indicates significant after Bonferroni correction for the 28 pathways (p-value < 0.0018)
aAnalyses were performed in children with complete data on genetic variants, at least one outcome under study, and covariates
bValues are linear regression coefficients for models adjusted for sex and the first four genetic principal components and represent the difference in standard
deviation scores of the outcome measures for each additional average risk allele in the risk scores
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Fig. 1 (See legend on next page.)
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possible [8]. As a comparison, we also ran a pathway
analysis using IPA. Results were comparable regarding
the major categories (eg. neurological development and
function, cell cycle, lipid metabolism, apoptosis). How-
ever, the IPA software showed a larger subdivision with
74 different pathways instead of 28 as suggested by the
GIANT consortium (Additional file 12, Table S9). The
overall adult WHR genetic risk score was only associated
with android/gynoid fat ratio (Table 3; Additional file 13:
Figure S4a-d). The childhood BMI genetic risk score was
associated with all childhood adiposity measures (Table 3;
Additional file 14: Figure S5a-d). The genetic risk score
based on 29 SNPs showed higher effect estimates per SD
increase than our 97 SNPs adult BMI risk score for the
childhood adiposity outcomes, especially for preperitoneal
fat area (Additional file 8, Table S5). The 97 adult BMI
SNPs explained 4.9 % of childhood BMI when added into
our model as individual SNPs. When the 97 SNPs were
combined into the weighted risk score and added to our
model, the risk score explained 1.4 % of childhood BMI
(Additional file 15: Table S10).
Discussion
We observed that a higher overall adult BMI genetic risk
score based on 97 SNPs was associated with BMIAP
during infancy, and with BMI, total fat mass, android/
gynoid fat ratio, and preperitoneal fat area during child-
hood. A genetic risk score based on SNPs in or close to
genes in the membrane proteins pathway was associated
with infant PWV, whereas genetic risk scores based on
pathways for neuronal developmental processes, hypo-
thalamic processes, cyclicAMP, WNT-signaling, mem-
brane proteins, monogenic obesity/energy homeostasis,
glucose homeostasis, cell cycle, and muscle biology were
associated with childhood adiposity measures. None of
the pathway risk scores were associated with preperito-
neal fat area.
Interpretation of main findings
Previous studies revealed a total of 97 loci related to adult
BMI [8]. In a previous study, we reported on the associ-
ation of a genetic risk score based on 29 adult BMI SNPs
known at that time with infant growth and childhood adi-
posity measures [12]. This risk score was associated with a
higher AGEAP and with a higher BMI, total fat mass, an-
droid/gynoid fat ratio, and preperitoneal fat area. In the
current study, we aimed to identify the effects of updated
and more detailed risk scores based on the 97 currently
known loci and on subgroups of loci representing specific
biological pathways on the same infant growth and child-
hood adiposity measures. Infant weight growth patterns
are known to be strongly associated with BMI in child-
hood and adulthood, and childhood BMI is associated
with obesity and cardiovascular disease in adulthood [1–4,
20, 22, 24]. Thus, it is important to understand the mo-
lecular pathways underlying childhood adiposity.
Our results suggest a modest effect of the adult BMI
risk score on infant weight growth measures. We ob-
served an association of the overall adult BMI genetic
risk score with BMIAP only. In our previous study,
based on 29 adult BMI SNPs, the genetic risk score was
associated with AGEAP only [12]. A recent study among
9,328 children reported an association of a genetic risk
score of 32 adult BMI-associated SNPs, including the 29
included in our previous risk score, with BMIAP, which
is in line with our current finding. Additionally, a weak
inverse association was found of this risk score with
AGEAP [29]. The difference in associations between the
previously published 29 SNP adult BMI risk score and
our current 97 SNP adult BMI risk score may imply that
the increased number of SNPs in the current genetic risk
score adds noise to the association of the 97 SNP adult
BMI risk score with childhood adiposity outcomes. Also,
the analyses were run in a slightly different population,
as siblings were excluded for the current study. The
added SNPs may be more representative of BMIAP. The
childhood BMI genetic risk score was associated with in-
fant PWV and BMIAP, which are both strongly associ-
ated with increased risk of overweight in childhood [23].
The overall adult BMI genetic risk score was also associ-
ated with all childhood adiposity measures, which is in
line with previous studies [12, 29, 30]. Some of these as-
sociations are partly explained by infant growth. The
WHR risk score was associated with childhood android/
gynoid fat ratio only, which is not surprising given the
close relation of android/gynoid fat ratio to WHR. Re-
sults for the childhood BMI risk score were similar to
the associations found with the adult BMI risk score, ex-
cept that effect estimates were much larger for the child
BMI risk score. Larger effect estimates may reflect stron-
ger effects of the childhood-specific SNPs in children.
Our results suggest that genetic risk scores based on
(See figure on previous page.)
Fig. 1 Association of adult body mass index genetic risk score with infant growth measures (N = 2,955). The x axis represents the categories of
the risk score (overall sum of risk alleles, weighted by previously reported effect estimates, rescaled to SDS. The risk score ranged from −4 to 3
SDS and was rounded to the nearest integer for clarity of presentation. The right y axis shows mean SDS and corresponds to the dots and the
line representing the regression of the mean SDS values for each category of the risk score. The y axis on the left corresponds to the histogram
representing the number of individuals in each risk-score category. P-value is based on the continuous risk score, as presented in Table 2. Graphs
represent; a peak weight velocity, b BMI at adiposity peak, and c age at adiposity peak
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Table 3 Associations of BMI, WHR, and childhood BMI genetic risk scores with childhood adiposity (N = 3,975)a, b
Risk score (number of SNPs in risk
score)
Body mass indexc Total fat massc,d,e Android/gynoid ratioc,d,e Preperitoneal fat areac,d,e
Beta (CI 95 %) P-value Beta (CI 95 %) P-value Beta (CI 95 %) P-value Beta (CI 95 %) P-value
Main risk scores*
Adult BMI (N = 97) 0.112 (0.084; 0.141) 1.01*10−14 0.092 (0.065; 0.119) 3.89*10−11 0.077 (0.045; 0.108) 2.00*10−6 0.034 (0.001; 0.066) 0.042
Secondary risk scores
Adult WHR (N = 47) −0.012 (−0.042; 0.017) 0.405 −0.012 (−0.040 0.016) 0.402 0.073 (0.041; 0.105) 8.00*10−6 0.029 (−0.004; 0.061) 0.088
Child BMI (N = 15) 0.091 (0.063; 0.119) 3.43*10−10 0.073 (0.046; 0.100) 1.40*10−7 0.081 (0.050; 0.112) 3.75*10−7 0.038 (0.006; 0.070) 0.020
Adult BMI pathway genetic risk scores**
Neuronal
Neuronal developmental processes
(N = 29)
0.018 (0.014; 0.023) 2.25*10-5 0.032 (0.003; 0.061) 0.031 0.038 (0.004; 0.071) 0.029 0.008 (−0.026; 0.042) 0.654
Neurotransmission (N = 10) 0.013 (−0.015; 0.042) 0.370 −0.003 (−0.030; 0.024) 0.827 0.002 (−0.029; 0.034) 0.876 −0.009 (−0.040; 0.023) 0.595
Hypothalamic expression and
regulation (N = 13)
0.099 (0.071; 0.128) 5.81*10−12 0.089 (0.062; 0.115) 1.29*10−10 0.080 (0.049; 0.111) 5.30*10−7 0.041 (0.009; 0.073) 0.013
Neuronal expression (N = 12) 0.017 (−0.012; 0.046) 0.240 0.020 (−0.008; 0.047) 0.165 0.036 (0.004; 0.068) 0.027 0.009 (−0.023; 0.041) 0.583
0.023 (−0.005; 0.052) 0.112 0.013 (−0.014; 0.041) 0.341 0.016 (−0.016; 0.048) 0.320 −0.001 (−0.033; 0.032) 0.972
Bone development (N = 9) 0.018 (−0.011; 0.064) 0.226 0.006 (−0.021; 0.033) 0.656 0.015 (−0.016; 0.047) 0.340 0.004 (−0.028; 0.036) 0.811
Signaling
MAPK1/extracellular signal-
regulated kinases (N = 9)
0.034 (0.006; 0.062) 0.018 0.037 (0.010; 0.064) 0.008 0.023 (−0.008; 0.054) 0.149 0.014 (−0.017; 0.046) 0.378
JAK (N = 2) 0.033 (0.005; 0.062) 0.023 0.020 (−0.007; 0.047) 0.150 0.012 (−0.020; 0.043) 0.457 0.007 (−0.025; 0.039) 0.676
CyclicAMP (N = 5) 0.046 (0.017; 0.075) 0.002 0.052 (0.024; 0.079) 2.75*10−4 0.039 (0.006; 0.071) 0.019 0.026 (−0.007; 0.058) 0.123
WNTSignaling (N = 6) 0.058 (0.030; 0.087) 6.10*10−5 0.029 (0.002; 0.057) 0.034 0.039 (0.007; 0.070) 0.016 0.032 (0.000; 0.064) 0.047
G-protein coupled receptor
Notch signaling (N = 2) −0.027 (−0.056; 0.001) 0.059 −0.028 (−0.055; 0.000) 0.046 −0.028 (−0.059; 0.003) 0.075 −0.028 (−0.060; 0.003) 0.080
Mitochondrial (N = 8) 0.040 (0.010; 0.070) 0.009 0.041 (0.012; 0.069) 0.005 −0.002 (−0.035; 0.031) 0.905 −0.003 (−0.037; 0.031) 0.877
Retinoic acid receptors (N = 6) 0.045 (0.017; 0.074) 0.002 0.037 (0.010; 0.065) 0.007 0.016 (−0.015; 0.047) 0.313 0.017 (−0.015; 0.049) 0.293
Endocytosis/exocytosis (N = 14) −0.012 (−0.041; 0.016) 0.400 −0.003 (−0.030; 0.024) 0.840 −0.021 (−0.053; 0.010) 0.178 −0.020 (−0.051; 0.012) 0.218
Eye-related (N = 5) 0.012 (−0.016; 0.041) 0.398 0.015 (−0.012; 0.043) 0.276 −0.012 (−0.044; 0.020) 0.456 0.003 (−0.029; 0.035) 0.845
Tumorigenesis (N = 11) 0.041 (0.012; 0.070) 0.006 0.020 (−0.008; 0.048) 0.161 0.017 (−0.016; 0.049) 0.312 0.013 (−0.020; 0.046) 0.431
Apoptosis (N = 13) 0.025 (−0.003; 0.054) 0.084 0.020 (−0.007; 0.047) 0.151 −0.008 (−0.039; 0.024) 0.621 −0.036 (−0.068; −0.004) 0.028
Membrane proteins (N = 12) 0.075 (0.046; 0.103) 2.44*10−7 0.044 (0.017; 0.071) 0.002 0.059 (0.028; 0.090) 1.93*10−4 0.011 (−0.021; 0.044) 0.495
Hormone metabolism/
regulation (N = 4)
0.021 (−0.008; 0.049) 0.161 0.043 (0.015; 0.070) 0.002 0.026 (−0.005; 0.057) 0.103 0.004 (−0.028; 0.036) 0.812
M
onnereau
et
al.BM
C
G
enetics
 (2016) 17:120 
Page
8
of
13
Table 3 Associations of BMI, WHR, and childhood BMI genetic risk scores with childhood adiposity (N = 3,975)a, b (Continued)
Purine/pyrimidine cycle
(N = 4)
0.013 (−0.016; 0.041) 0.379 0.004 (−0.023; 0.031) 0.762 −0.017 (−0.048; 0.014) 0.285 −0.007 (−0.038; 0.024) 0.661
Monogenic obesity/energy
homeostasis (N = 9)
0.074 (0.045; 0.102) 4.74*10−7 0.068 (0.041; 0.095) 1.00*10−6 0.065 (0.034; 0.096) 5.00*10−5 0.030 (−0.003; 0.062) 0.072
Immune system (N = 15) 0.045 (0.017; 0.074) 0.002 0.037 (0.010; 0.065) 0.008 0.021 (−0.011; 0.052) 0.193 −0.008 (−0.040; 0.024) 0.620
Limb development (N = 3) 0.035 (0.007; 0.064) 0.015 0.024 (−0.006; 0.049) 0.125 0.028 (−0.003; 0.060) 0.076 0.004 (−0.028; 0.036) 0.794
Ubiquitin pathways (N = 6) −0.007 (−0.036; 0.021) 0.617 0.006 (−0.021; 0.034) 0.656 −0.011 (−0.043; 0.020) 0.483 −0.015 (−0.047; 0.017) 0.359
Glucose homeostasis/diabetes
(N = 11)
0.050 (0.021; 0.079) 0.001 0.023 (−0.004; 0.051) 0.096 0.042 (0.011; 0.074) 0.008 0.009 (−0.023; 0.042) 0.575
Cell cycle (N = 23) 0.044 (0.016; 0.073) 0.002 0.047 (0.019; 0.074) 0.001 0.024 (−0.007; 0.055) 0.135 0.007 (−0.025; 0.039) 0.684
DNARepair
Nuclear trafficking (N = 4) −0.005 (−0.034; 0.023) 0.716 −0.009 (−0.036; 0.018) 0.518 −0.004 (−0.036; 0.028) 0.804 −0.008 (−0.041; 0.024) 0.608
Muscle biology (N = 6) 0.048 (0.020; 0.077) 0.001 0.029 (0.002; 0.057) 0.038 0.025 (−0.007; 0.056) 0.127 0.022 (−0.010; 0.054) 0.181
* Bold font indicates P-value < 0.05. ** Bold font indicates significant after Bonferroni correction for the 28 pathways (p-value < 0.0018)
aAnalyses were performed in children with complete data on genetic variants, at least one outcome under study, and covariates
bValues are linear regression coefficients for models adjusted for sex and the first four genetic principal components and represent the difference in standard deviation scores of the outcome measures for each
additional average risk allele in the risk scores
cValues are additionally adjusted for age
dValues are additionally adjusted for height
eRegression coefficients are based on standard deviation scores of ln-transformed outcome measures
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adult BMI, WHR and childhood BMI influence child-
hood adiposity outcomes, and also BMI growth patterns
from infancy onwards.
The 97 SNPs in our risk score explained 2.7 % of the
adult BMI variance in the original paper [8]. In the
current study we found that the same SNPs, when added
simultaneously to our regression model, account for
4.9 % of childhood BMI suggesting a larger effect of
these SNPs in childhood than in adulthood. This may be
due to a relative increase in the effects of environmental
factors over time. It should be noted that this estimate
represents the upper bound of the phenotypic variation
accounted for by the 97 SNPs, due to the method of en-
tering all SNPs simultaneously to the model rather than
combined into a risk score. When combined into a
weighted risk score the 97 SNPs explained only 1.5 % of
childhood BMI. We previously reported on a genetic risk
score combining only 29 adult BMI SNPs, which explained
2.4 % of the variance in BMI in children of the Generation
R Study [12]. Increasing the number of adult SNPs from
29 to 97 thus seemed to add noise to our risk score. It may
be that some genetic loci show age-dependent associations
with BMI, with different effects in children as compared to
adults [31, 32]. Previous work has described an inverse
association of the fat mass and obesity related locus (FTO)
with BMI before the age of 2.5 years, no association be-
tween 2.5 and 5 years, and a positive association from
around the age of 5 years onwards. The association then
strengthens with age, reaching its peak at the age of
20 years and subsequently weakens again [31, 32]. A similar
age dependent pattern has been observed for the melano-
cortin 4 receptor (MC4R) locus [32].
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Fig. 2 Association of adult body mass index genetic risk score with childhood adiposity measures (N = 3975). The x axis represents the categories
of the risk score (overall sum of risk alleles, weighted by previous reported effect estimates, rescaled to SDS. The risk score ranged from −4 to 3
SDS and was rounded to the nearest integer for clarity of presentation). The right y axis shows the mean SDS and corresponds to the dots and a
line representing the regression line of the mean SDS values for each category of the risk score. The y axis on the left corresponds to the histogram
representing the number of individuals in each risk-score category. P-value is based on the continuous risk score, as presented in Table 3. Graph a-d
represent; a BMI in kg/m2, b ln (fat mass percentage), c ln (android/gynoid fat ratio), and d ln (preperitoneal fat area)
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Our results showed that during infancy only the mem-
brane proteins pathway affects PWV. This pathway in-
volves membrane proteins that play a role regulating
different cell processes involved in e.g., apetite, cholesterol
synthesis, and gene expression [8]. Our findings suggest
that these processes are also important for weight growth
during early life. None of the other pathways were associ-
ated with infant growth measures. In line with previous
adult studies, a strong role was observed for central ner-
vous system related processes in pathways associated with
childhood adiposity measures [8, 33]. Especially the hypo-
thalamic expression and regulation pathway is suggested to
be important, which is confirmed in our analyses [8, 31].
Mutations in some of the genes in the monogenic obesity/
energy homeostasis related pathways are also suggested to
act via central nervous system related processes [33]. The
hypothalamic expression and regulation and the mono-
genic obesity/energy homeostasis pathways were associated
with childhood BMI, total fat mass, and android/gynoid fat
ratio. The other pathways that were associated with BMI
suggest a role for fasting/feeding related processes, glucose
homeostasis, signaling, and diabetes related pathways. Our
findings suggest a stronger role for the predefined categor-
ies during childhood than during infancy, which may be
because the childhood measures are more closely related
to adult BMI.
Reported total heritability estimates for childhood BMI
from twin studies are as high as 80 %. In the current study
we found that a risk score based on the known SNPs only
explained 1.5 % of the variation in child BMI, emphasizing
that a large part of the heritability remains to be discov-
ered [5, 6]. In addition to SNPs, other sources of (epi-)
genetic variation, such as copy number variants (CNV)
and differences in methylation, may also contribute [34,
35]. A large part of the common CNVs have been effi-
ciently tagged by SNPs in GWA studies [36]. However, as-
sociations of rarer CNVs with BMI and obesity showed
mixed results [35, 37, 38]. Recently, methylation at specific
sites in the DNA has been associated with BMI in adults
and children [34, 39, 40]. Additional research in larger
study populations is needed to further disentanble the
(epi-) genetic background of BMI in children and adults.
Methodological considerations
The large number of participants and available detailed
phenotypes is a major strength of the study. Of all children
with genetic data, information on infant growth measures
was available for 54 %. Measures of childhood general and
abdominal adiposity were available in 72 % of all children.
Children without information on infant growth measures
had a higher BMI, total fat mass, android/gynoid fat ratio,
and preperitoneal fat area (all p-values < 0.001) compared
with the participants included in our analyses. This may
have resulted in an underestimation of the association for
the risk scores with infant growth and childhood adiposity
measures. Detailed measurements of childhood abdominal
adiposity were performed. Both DXA and abdominal ultra-
sound are considered valid methods for such measure-
ments [24, 26]. Not all SNPs were available in our GWAS
dataset. We used a limited number of proxies in very high
linkage disequilibrium to complete the sets of SNPs for
adult BMI, WHR, and child BMI. No good proxies were
available for two WHR SNPs. Given the high number of
SNPs available, all risk scores are considered a good repre-
sentative of the original set of adult SNPs. Although our
population is relatively large, we still may have had limited
power for these analyses, leaving a possibility of underesti-
mating the number of associated pathways.
Conclusions
A genetic risk score based on 97 loci associated with adult
BMI was associated with PWV during infancy and with
general and abdominal fat measurements in childhood.
Our results suggest that the genetic background and the
pathways involved in adult and childhood adiposity at least
partly overlap. Adult BMI related biological pathways in-
volved in neuronal developmental processes, hypothalamic
expression and regulation, cyclicAMP, WNT-signaling,
membrane proteins, monogenic obesity/energy homeosta-
sis, glucose homeostasis, and cell cycle likely influence adi-
posity from early life onwards. Further studies are needed
to identify more (rare) loci and unravel the underlying
mechanisms of childhood adiposity.
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